The Congressional Budget Office needs another two weeks to complete its analysis of the legislation, giving the House no time to vote before the Thanksgiving recess, according to The Hill.
This is the second time the vote has been pushed back because the budget office’s analysis is taking longer than expected.
Ms. Pelosi’s bill is expected to pass on a party line vote in the House but die in the Republican-controlled Senate.
It is possible that some smaller drug pricing measures will be included in a government funding deal at the end of the year, but that is uncertain, according to The Hill.
The White House has also expressed favor for a bipartisan bill from Sens. Chuck Grassley (R-Iowa) and Ron Wyden (D-Ore.) over Ms. Pelosi’s bill. Democrats are still pushing for changes to Ms. Pelosi’s bill as well.
More articles on pharmacy:
Amgen exits neuroscience research, cuts 180 US jobs
Walgreens’ exit from health clinic business should serve as a warning to rivals
Top 10 pharmacy stories in October
More articles on pharmacy:
Amgen exits neuroscience research, cuts 180 US jobs
Walgreens’ exit from health clinic business should serve as a warning to rivals
Top 10 pharmacy stories in October
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
